Cibc World Market Inc. Reduces Stock Position in Healthpeak Properties, Inc. $DOC

Cibc World Market Inc. reduced its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 63.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,107 shares of the real estate investment trust’s stock after selling 126,193 shares during the period. Cibc World Market Inc.’s holdings in Healthpeak Properties were worth $1,564,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of DOC. OneDigital Investment Advisors LLC grew its stake in Healthpeak Properties by 3.3% in the second quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust’s stock worth $329,000 after purchasing an additional 493 shares in the last quarter. Clearstead Trust LLC increased its holdings in Healthpeak Properties by 66.7% in the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 543 shares during the last quarter. CX Institutional raised its stake in Healthpeak Properties by 6.1% during the second quarter. CX Institutional now owns 11,003 shares of the real estate investment trust’s stock valued at $235,000 after buying an additional 633 shares in the last quarter. Fiduciary Trust Co raised its stake in Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock valued at $264,000 after buying an additional 644 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after buying an additional 718 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 1.6%

NYSE:DOC opened at $21.23 on Friday. The firm has a market capitalization of $14.64 billion, a P/E ratio of 60.67, a P/E/G ratio of 2.35 and a beta of 1.01. The business has a 50 day simple moving average of $21.52 and a 200 day simple moving average of $19.17. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.02 and a quick ratio of 3.02. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.95.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The company had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same period last year, the business posted $0.46 earnings per share. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities research analysts predict that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is 348.57%.

Analysts Set New Price Targets

Several research analysts have recently commented on DOC shares. BMO Capital Markets lifted their target price on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, June 15th. Scotiabank upped their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Cantor Fitzgerald raised their price objective on Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. lifted their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Finally, Weiss Ratings upgraded shares of Healthpeak Properties from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, August 19th. Four equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $21.66.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.